Evidence map›Paper›PMID 25005656›Full record

ArticleJAMA2014

Antiepileptic drugs for neuropathic pain and fibromyalgia.

Andrew Moore, Philip Wiffen, Eija Kalso

Abstract readComment
PubMed Publisher
In one paragraph

Article in JAMA, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Management of lumbar zygapophysial (facet) joint pain.World journal of orthopedics · 2016
    Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Andrew MoorePain Research and Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, England.
Philip WiffenPain Research and Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, England.
Eija KalsoDepartment of Anaesthesia, Intensive Care Medicine, Emergency Medicine, and Pain Medicine, Helsinki University Central Hospital, Helsinki, Finland3Institute of Clinical Medicine, University of Helsinki, Finland.
University of Oxford · GBUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

clinical questionAre antiepileptic drugs associated with reduced pain intensity in patients with neuropathic pain or fibromyalgia? BOTTOM LINE: In treating diabetic neuropathy and postherpetic neuralgia compared with placebo, gabapentin and pregabalin are associated with a modest increase in the number of patients experiencing meaningful pain reduction. In treating fibromyalgia, compared with placebo, pregabalin alone is associated with a small increase in the number of patients experiencing meaningful pain reduction. There is insufficient evidence for other antiepileptics.

Indexed as

AnticonvulsantsFibromyalgiaHumansNeuralgiaAnticonvulsants

Identifiers

PMID25005656
OpenAlexW2127064566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.